Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2004
01/27/2004US6682894 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation
01/27/2004US6682892 Screening for modulator of viral infectivity; obtain modulator, incubate with virus, monitor infectivity of virus
01/27/2004US6682890 Methods of diagnosing and determining prognosis of colorectal cancer
01/27/2004US6682888 Genes expressed in alzheimer's disease
01/27/2004US6682886 Bivalent binding molecules of 7 transmembrane G protein-coupled receptors
01/27/2004US6682883 Chimeric virus comprises nucleic acid sequences derived from predetermined flavivirus structural genes prm-e, the other a flavivirus used as chimera backbone; inoculating mammal with chimeric virus for animal model of infection
01/27/2004US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells
01/27/2004US6682704 Reducing malfunctioning
01/27/2004US6682700 Free-standing fluid sensors, filters, and catalyst devices, and methods involving same
01/27/2004US6682649 Substrate and a method for determining and/or monitoring electrophysiological properties of ion channels
01/27/2004US6682648 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
01/27/2004US6682638 Film type solid polymer ionomer sensor and sensor cell
01/27/2004US6681617 Variable eccentric rheometer system
01/27/2004CA2322465C Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels
01/27/2004CA2309450C Nanoelectrode arrays
01/27/2004CA2307141C Method and apparatus for making arrays
01/27/2004CA2258489C High-throughput screening assay systems in microscale fluidic devices
01/27/2004CA2191238C Dental impression material with cure-indicating dye
01/27/2004CA2105644C Resurfacing of rodent antibodies
01/27/2004CA2080428C A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test
01/27/2004CA2002607C Natural killer stimulatory factor
01/24/2004CA2435789A1 System and cartridge for processing a biological sample
01/23/2004CA2433473A1 Fluorescent hybridization probes with reduced background
01/22/2004WO2004008480A2 Quantitative analysis via isotopically differentitated derivatization
01/22/2004WO2004008462A1 Method for eddy-current test of gadolinium content in each pellet of uranium-gadolinium fuel column in a fuel element and device for carrying out said method
01/22/2004WO2004008371A1 Peptide and protein identification method
01/22/2004WO2004008369A2 A decision criterion based on the responses of a trained model to additional exemplars of the classes
01/22/2004WO2004008361A1 Information processing system using base sequence relevant information
01/22/2004WO2004008279A2 Computer user interface facilitating acquiring and analyzing of biological specimen traits
01/22/2004WO2004008153A2 Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr)
01/22/2004WO2004008152A1 Method for screening ebna-1 inhibitors
01/22/2004WO2004008151A2 New combinatorial peptide libraries containing markers and methods for their preparation and utilization
01/22/2004WO2004008150A1 Methods to identify true antagonists and inverse agonists of the cannabinoid receptor
01/22/2004WO2004008149A1 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases
01/22/2004WO2004008148A1 Method for detection of bioactive peptides
01/22/2004WO2004008147A2 Diagnosis and prevention of cancer cell invasion
01/22/2004WO2004008146A2 Test strips moveable by magnetic fields
01/22/2004WO2004008145A1 Method to prepare diagnostic films using engraved printing cylinders such as rotogravure
01/22/2004WO2004008144A2 Method capable of being automated for detection of prpres and uses thereof
01/22/2004WO2004008143A1 Method for determining the number of receptors on a carrier
01/22/2004WO2004008142A1 Analytical chip, analytical chip unit, analyzing apparatus, method of analysis using the apparatus, and method of producing the analytical chip
01/22/2004WO2004008140A2 Plasma urotensin in human heart failure
01/22/2004WO2004008139A1 Absorbent for diagnosis and absorption article
01/22/2004WO2004008137A2 Diagnosis and therapy of breast tumours resistant to antiestrogen treatment
01/22/2004WO2004008136A1 Determining the constitution of combustible gases by measuring the thermal conductivity, thermal capacity and carbon dioxide content
01/22/2004WO2004008135A2 Method for online measurement of molten phases
01/22/2004WO2004008129A2 Method and device for monitoring moisture content of an immersed solid dielectric material
01/22/2004WO2004008122A1 Sensitizer-labeled analyte detection
01/22/2004WO2004008105A2 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement
01/22/2004WO2004008102A2 Liver tumor marker sequences
01/22/2004WO2004008099A2 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
01/22/2004WO2004008098A2 NON-INVASIVE MEASUREMENT OF pH
01/22/2004WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors
01/22/2004WO2004007769A1 Method of screening remedy for aids
01/22/2004WO2004007767A2 Serrs reactive particles
01/22/2004WO2004007761A1 Method to reduce false positive outcomes in prion tests
01/22/2004WO2004007760A1 Method of decomposing protein with sulfonic acid compound
01/22/2004WO2004007758A1 Novel method of selecting immunosuppressant having little thrombocytopenic effect
01/22/2004WO2004007757A1 Method for identifying individual active entities from complex mixtures
01/22/2004WO2004007754A2 Modulators of cellular proliferation
01/22/2004WO2004007753A2 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements
01/22/2004WO2004007747A2 Assays for assembly of ebola virus nucleocapsids
01/22/2004WO2004007746A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN
01/22/2004WO2004007745A2 Method for chemiluminescent detection
01/22/2004WO2004007726A2 Brachyspira hyodysenteriae vaccine
01/22/2004WO2004007725A1 Polypeptide of streptococcus pyogenes
01/22/2004WO2004007722A2 Transgenic animal expressing alzheimer’s tau protein
01/22/2004WO2004007716A1 Method of isolating gpcr gene and novel gpcr gene
01/22/2004WO2004007710A1 Solid support having electrostatic layer and use thereof
01/22/2004WO2004007708A1 Modulation of cytochrome p450 reductase activity
01/22/2004WO2004007702A2 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________
01/22/2004WO2004007701A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use
01/22/2004WO2004007692A2 Methods and compositions for analyzing polymers using chimeric tags
01/22/2004WO2004007671A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN
01/22/2004WO2004007669A2 Protein chips
01/22/2004WO2004007555A2 Detection of prion disease
01/22/2004WO2004007554A1 Protein for diagnosing diabetic retinopathy
01/22/2004WO2004007549A1 Process for the purification of interleukin-4 and its muteins
01/22/2004WO2004007547A2 Truncated tau proteins
01/22/2004WO2004007544A2 Components of the presenilin-complex
01/22/2004WO2004007534A1 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A THIOREDOXIN-LIKE 32 kDA PROTEIN
01/22/2004WO2004007531A2 Activated checkpoint therapy and methods of use thereof
01/22/2004WO2004006985A2 Assaying and imaging system identifying traits of biological specimens
01/22/2004WO2004006956A1 Drugs for improving the prognosis of brain injury and a method of screening the same
01/22/2004WO2004006955A1 Super humanized antibodies
01/22/2004WO2004006951A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
01/22/2004WO2004006898A2 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease
01/22/2004WO2004006866A2 Antifungal therapeutic targets
01/22/2004WO2004006861A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
01/22/2004WO2004006844A2 Method for identifying salt-sensitive persons
01/22/2004WO2004006840A2 Three dimensional cell patterned bioploymer scaffolds and method of making the same
01/22/2004WO2004006753A2 Sga-72m, a cancer associated antigen, and uses thereof
01/22/2004WO2004006662A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARα GENE TRANSFERRED THEREINTO AND USE THEREOF
01/22/2004WO2003102542A3 Comparative proteomics of progressor and nonprogressor populations
01/22/2004WO2003102539A3 Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
01/22/2004WO2003102143A3 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1)
01/22/2004WO2003099104A3 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma
01/22/2004WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor
01/22/2004WO2003093495A3 Diffraction-based diagnostic devices
01/22/2004WO2003089906A3 Functionalized nanoparticles and methods of use